Antihypertensive therapy with beta blockers;Antihypertensive differentialtherapie mit beta-rezeptoren-blockern

Herz Kreislauf

Volumn 30, Issue 2, 1998, Pages 47-55

  Scholze, J ^a,b  

^a Medizinische Poliklinik   (Germany)

^b Medizinische Poliklinik   (Germany)

Author keywords

Beta blockers; Differential therapy; Hypertension

Indexed keywords

ACEBUTOLOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CARTEOLOL; CELIPROLOL; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MEPINDOLOL; METOPROLOL; NADOLOL; NEBIVOLOL; OXPRENOLOL; PENBUTOLOL; PROPRANOLOL; SOTALOL; TALINOLOL; TIMOLOL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; HEART INFARCTION; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; ORAL DRUG ADMINISTRATION; SECONDARY PREVENTION;

EID: 0031938449     PISSN: 00467324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Aarons, R.D., Nies, A.S., Gal, J., Hegstrand, L.R., Molinoff, P.B.: J. Clin. Invest. 65, 949-957 (1980)
2. Abshagen U: J. Cardiovasc. Pharmacol. 10 (suppl 23 32 :I987)
3. Amery, A., Billiet, L., Boel. A., Fagard, R.. Rebrouck. T.. Willems, J.: Ant. Heait J 91. 634 -642 (1970!
4. Amery, A.. Birkenhäger, W., Brixko, P.. et al.: Lan l I. 1349- .',154 (13851
5. SAnderson. J.L.. Lutz. J.R.. Gilbert, E.M., Sorensen. S.G.. Yanowitz, F.G., Menlove, R.L.. Bartholomew. M.: Am. j. Caidiol. 55. 471 -475 {19851
6. Benson. M.K.. Berrill, W.T., Cruickshank, J.M., Sterling, G.S.: Bi. J. Clin Phaimacol r>. 415-419 [1978)
7. Berlan, M.. Galitzky, J., Montastruc, J.L.: Fundam. Clin. Pharmacol. 9, 234-239 (1995)
8. Betts, T.A., Alford, C.: Diugs 25 (Suppl 2), 268-272 (1983}
9. CIBIS Investigators and Committees: Circulation 90. 1765-1773(1994)
10. Cove-Smith. R., Kirk, ÇA: Br. Med. J. 286. 1650-1651 1/983)
11. Cruickshank. J.M., Higgins, U.C.. Pennert, K., Thorp. J.M., Zacharias. RM., Zacharias, F.J.: J. Human Hypertension I. 87-93 (1987)
12. Cruickshank. J.M., Prichard, B.N.: Churchill Livingstone. Longman Group UK Limited 1988
13. Cruickshank, J.M.: Acta Ther. 7, 309-321 (1981)
14. D'Allaire, F, Atgie, C., Maurige, P., Simard, P.M.. Bukowiecki, L.J.: Br J. Pharmacol. 114, 275-282 (1995)
15. ISDahlöf, B.. Lindholm, L.H., Hansson, L.. Scher-stén, B., Ekbom. T., Wester, P.O.: Lancet 338. 1281-1285 (1991)
16. Deacon. S.P., Barnett. D.: Br. Med. J. 2. 272-273 (1976)
17. Deacon, S.P., Karunanayake, A., Barnett. D.: Br Med J 2. 1255-1257 (1977) IBDecalmer, P.B.S., Chatterjee, S.S.. Cruickshank, J.M., Benson, M.K., Sterling, M.G.: Br. Heart J. 40. 184-189 (1978)
18. Dehner, R., Ikeda, K., Yamori. Y: Z. Kardiol 79 (supp!3). 79-88 (1990)
19. Deutsche Liga zur Bekämpfung des hohen Blutdruckes: Empfehlungen zur Hochdruckbehandlung in de/ Praxis und zur Behandlung hypertensiver Notfälle. 13th Edition (1997)
20. Ellis, M.E., Sahey, J.N., Chatterjee. S.S.. et al..: Eur. J Clin. Pharmacol. 21 173-l76 (1981)
21. Emorine, L.J., Marullo, S., Briend-Sutren, M.-M., et al..: Science 245, 1118-1121 (1989)
22. Fellenius, E.: Int. J. Sports Med. 4, 1-8 (1983)
23. Fischer-Hansen. J, Hagerup, L., Sigurd, B, et al.: Am J Cardiol. 79, 738-741 (1997)
24. Franz. I.-W.: Hypertonie und Herz. Diagnostische, piognostische und therapeutische Aspekte. Springer Verlag. 1991
25. Franz, l .W., Lohmann. F.W.: Vet h. Dtsch. Ces Inn Med. 87. 518-5? l (1981)
26. Gerstenbrand, F., Klinger, D., Poewe, W.: Nei-venaizt 53. 435-44; (1982}
27. 28Greminger, P.. Vetter. H., Boerlin. HJ. et al.: Diuqs25 (Supt)l 2t. 37-41 (l383}
28. Hayes. P.C.. Davis, J.M., Lewis, J.A.. Bouchier. I.A.D.: Lant 336. 153-156 1.1990}
29. Henningsen. N.C.. Mattiasson, !.. Ohlsson, 0., Arborelius. M.. Bylow, K.: Proceedings of Eightth Woilü Congress öl Cardiology. Abstillet 1049. Tokyo 1978
30. HINT Research Group: Report of the Holland Interuniversity Nifedipine/Metoprolol Trial [HINT] Research Group: Bi Heart J 56. 400-4/3 (1986)
31. Hjalmarson, A.. Elmfeldt. D.. Herlitz. J.. et al.: Lancet 2. 823-827(1981}
32. 32a Hjalmarson. A, Olsson. G.: Ciicuk'ition 04 (Suppl) 6; VI 101 -VI 107 (1991)
33. Holzgreve. H.. Middecke. M.: Drugs 46' (Suppl2). 24 31 ! 19931
34. Holt. D.W., Bhamra, R., Thorley. K.J.. et al.: ; J. Clm. Pharmacol 14. 148-149(1982}
35. Ingemarsson. liedholm, H.. Montan, S., Westgren, M.. Melander. A.: Acta Obstet Gynecol. Scand 118 iüiippl). .95-97 (1984)
36. ISIS- l (First International Study of Infarct Survival) Collaborative Group: Lancet 1. 921-923 (1988}
37. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 6th leport o! the Joint National Committee on Detection. Evaluation ami Treatment o! High Blood Presume (JNCV). National High Blood Pressure Education Program (1997)
38. Kolendorf. J., Aerenlund Jensen, H., Holst. J.J.. Poulsen. J.E.: Scjncl J. Clm. Lib. Invest. 42. 69-74 (1982;
39. Kostis. J.B.. Rosen. R.C.: Circulation 75. 204-212 (1987}
40. Krauss. S.. Spitz, E., Grizotzki. B., Clement, S.: Angioloyy 35. 773-778 (1984)
41. Lamas. G.A.. Flaker. G.C., Mitchell, G., Smith, S.C.. Gersh, B.J., Wun, C.C., Moye. L, Rouleau, J.L., Rutherford. J.D.. Pfeffer, M.A., Braunwald, E. for the Survival and Ventricular Enlargement Investigators: Circulation 92. 1101-1109(1995)
42. Landauer, A.A., Pocock. D.A., Prott, F.W.: Psyohophaimacol GO. 2/1-215 (1979)
43. Lands. A.M.. Arnold, A., McAucliff, J.P., Luduena, F.P., Brown. T.G.: Nature 214. 597 (1967)
44. Lauridsen. U.B., Christensen, N.J., Lyngsoe, J.: J Clm Endocnnol Metan 56. 876-882 (1983)
45. Lawrence. D.S.. Sahey, J.N., Chatterjee, S.S.. Cruickshank, J.M.: Eur. J. Clm. Phaimacol. 22. 501 -509(1982)
46. Liedholm, H.: Diugs 25 (Suppl 2), 206-211 (1983)
47. Lithell, H.O.: Diabetes Ca/e 14. 203-209 (1991)
48. Materson, B.J., Reda. D.J., Cushman, W.C., et al.: N EngJ. J. Med. 328, 914-921 (1993)
49. McTavish, D., Campoli-Richards, D., Sorkin, E.M.: Drugs 45. 232-258 (1993)
50. Medical Research Council Working Party: Br. Med J 291. 97-104 (1985)
51. Merx W: In: Maurer, W., Schömig, A., Dietz, R., Lichtlen, P.R. (Hrsg.): Beta-Blockade 1977. Im SympRottach-Egern. Thieme, Stuttgart. 360 (1978)
52. Michel, M.C.. Pingsmann. A., Beckeringh, J.J., Zerkowski, H.R., Doetsch, N., Brodde, O.E.: Br. J. Phaimacol. 94. 685-692 (1988)
53. Neil-Dwyer, G., Bartlett, J. McAinsh, J., Cruickshank. J.M.: Bi J Clm Phaimacol. 11. 549-553 (1981}
54. 540pie, L.H., Jee. L., White, D.: Am Henri J. 104. 606-612(1982)
55. Packer, M., Bristow. M.R., Cohn, et al..: Circulation 92 (Suppl l). 142(1995)
56. Philipp, Th., Anlauf, M., Distler, A. on behalf of the HANE Trial Researcli Group: BMJ 315. 154-159 (1997)
57. Pitt, B., Segal, R., Martinez, F.A., et al.: Lancet 349. 747-752 (1997j
58. Pepine, C.J., et al.: Circulation 90. 762-768 (1994)
59. Roberts, R.. Rogers, W.J., Mueller, H.S., et al., for the TIMI Investigators: Circulation 83. 422-437 (1991)
60. Rubin, P.C., Butters. L., Clark. D. et al.: Lancet I 431-434 (1983)
61. Rubin. P.C., Butters, L., Low, R.A., Reid, J.L.: Bi Clm. Pharrnacol 14. 279-281 (1982l
62. Ryden, L.. Ariniego, R., Ammann, K., et al: N Eng/ J. Med 308. 614-618 (1983)
63. Scholze, J., Klein, G.: Clm. Drug Invest. 11 331-338 (1996)
64. 64SHEP: JAMA 1265. 3255-3264 (19911
65. Sponer, G., Bartsch, W., Strein, K.: J. Caidiovasc. Pharmacol. 9. 317-327 (1987)
66. Sponer, G., Strein, K., Müller-Beckmann, B., et al.: J Caidiovusc. Phaimacol. 10 (Suppl 11). 42-48 (1987)
67. Strein, K., Sponer, G.: Z. Kaidiol 79 'suppl 3) 89-98 (1990)
68. Taylor, S.H., Silke, B Ebbutt, A., Sutton, G.C., Prout, B.J., Burley, B.M.: N. EngJ. J. Med 307. 1293-1301 (1982)
69. The Australian and Swedish Pindolol Study group: Ew. Heart J 4. 367-375 (1993t
70. The BHAT research group: J. Am. Med Assoc 247. 1707-1714 (1982)
71. The EIS group: Ew. Heart J. 5. 189-202 , 184)
72. The IPPPSH Collaborative Group: J. Hypei'ens 3. 379-392 (1985)
73. The MIAMI trial research group: Eu/ Heait J. 6 199-226(1985)
74. The Norwegian Multicenter Study Group: AJ. Engl. J. Med. 304, 801-807 (1981.J
75. Tyrer, P.J.: Drugs 20, 300 (1980)
76. Waagstein, F., Bristow, M.R., Swedberg, K.. Camerini, F., Fowler, M.B., Silver, MA, Gilbert, E.M., Johnson, M.R., GOSS, F.G.. Hjalmarson, A. for the Metoprolol in Dilated Cardiomyopathy [M DC] Trial Study Group: Lanl 342 1441-1446 11993)
77. Waagstein, F., Hjalmarson, A., Varnauskas, E.. Wallentin, I.: Br. HeanJ 37 1022 1036 (1975l
78. Warren, D.J., McSorley, P., Naik, R.B.: VIII Woiltl Congress of Caidio/oç/y. Tokyo (ahsli.) !197ti!
79. Weber, R.B., Reinmuth, O.M.: Neuiulogy 22. 366-369 (1972)
80. Weiner. L., Rossner, S.: Ninth Scient/fie Meeting of the International Society of Hypertension. Mexico. 440 (abstr) (1982)
81. Westerlund, A: N. Engl J. Med 307 1343-1344 (1982)
82. 82Wikstrand. J., et al.: JAMA 259 1976 1982 (1988)
83. Wilhelmsen. L, Berglund, G.. Elmfeldt, D., et al. on behalf of the Heart Attack Primary Prevention in Hypertension Trial Research Group: / J Hypertens. 5. 561-572 ; 1987l
84. Wörz, R., Reinhardt-Benmalek, B Föh, M., Grotemeyer, K.-H., Scharafinski, H.W.: Fortschi. Meil l W, 268-272 (1992}
85. Yusuf. S., Peto, R., Bennett. D. Ramsdale, D., Furse, L., Bray. C.. Sleight. P.: Lancet 2, 273-276 (1980)
86. Zacharias, F.J., Cuthbertson, P.J.R.. Prestt, J.. et al.: Postgrad. Med. j 53 !Snppl. 3). 192-11U (1977)
87. Zacharias. F.J.: Postgrad Med J. 53 (Suppl. 3t 111-113 (1977)
88. Zanchetti, A., Chalmers, J.P., Arakawa. K., et al.: Blood Press 2. 86-100 /1993)